10.6084/m9.figshare.7423457.v1 Wang L. Wang L. Xu J. Xu J. Tian X. Tian X. Lv T. Lv T. Yuan G. Yuan G. Supplementary Material for: Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia Karger Publishers 2018 CLAG Efficacy Safety Predictive factors Refractory or relapsed acute myeloid leukemia 2018-12-05 14:50:47 Dataset https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Analysis_of_Efficacy_and_Prognostic_Factors_of_CLAG_Treatment_in_Chinese_Patients_with_Refractory_or_Relapsed_Acute_Myeloid_Leukemia/7423457 <b><i>Background/Aims:</i></b> The aim of this work was to investigate the efficacy and predictive factors of CLAG treatment in refractory or relapsed (R/R) acute myeloid leukemia (AML) patients. <b><i>Methods:</i></b> Sixty-seven R/R AML patients were enrolled in this prospective cohort study and treated by a CLAG regimen: 5 mg/m<sup>2</sup>/day cladribine (days 1–5), 2 g/m<sup>2</sup>/day cytarabine (days 1–5), and 300 μg/day filgrastim (days 0–5). The median follow-up duration was 10 months. <b><i>Results:</i></b> A total of 57 out of 67 patients were evaluable for remission after CLAG therapy, of whom 57.9% achieved a complete remission (CR) and the overall remission rate was 77.2%. The median overall survival (OS) was 10.0 months, with a 1-year OS of 40.3 ± 6.0% and 3-year OS of 16.7 ± 5.7%. CR at first induction after the initial diagnosis was associated with a favorable CR. Age above 60 years, high risk stratification, second or higher salvage therapy, and bone marrow (BM) blasts ≥42.1% were correlated with an unfavorable CR. Secondary disease, age ≥60 years, high risk stratification, and second or higher salvage therapy were associated with worse OS. Patients developed thrombocytopenia (41, 61%), febrile neutropenia (37, 55%), leukopenia (33, 49%), neutropenia (18, 27%), and anemia (9, 13%). <b><i>Conclusion:</i></b> CLAG was effective and well tolerated for R/R AML. BM blasts ≥42.1%, age ≥60 years, high risk stratification, and second or higher salvage therapy were independent factors for a poor prognosis.